FORT COLLINS, Colo., April 26, 2017 -- Prieto Battery, an advanced 3D Lithium Ion battery technology company, today announced that it has entered into an agreement with Moses Lake Industries to pursue a technical collaboration for the electroplating and manufacturing of Prieto’s anode.
Moses Lake Industries (MLI) is a leading global supplier of high-performance chemical solutions to the semiconductor and flat panel industries. One of MLI’s core capabilities is high volume electroplating and the key reason Prieto was drawn to this collaboration. “As Prieto moves towards optimizing our technology, we’ve always been in search of an electroplating partner that can share our vision and is committed to helping us introduce this tenured methodology into the battery sector. We believe MLI is that partner,” said Dr. Amy Prieto, CEO/CSO and Founder of Prieto Battery.
The Memo Of Understanding covers a set time period of stepped milestones all driven to deliver commercially-viable anodes to Prieto’s key strategic partners and the broader battery market worldwide. Hiro Era, President of MLI, said, “We recognize Prieto Battery’s technology as a game-changer in the battery industry, and we are looking forward to a long term partnership with Prieto to scale this technology and get it out in the marketplace as quickly as possible.”
About Prieto Battery
Prieto Battery Inc., a Colorado company, was founded in June 2009 to accelerate the shift of Prieto’s innovations from the research laboratory to the commercial marketplace. The Company’s mission is to commercialize a patented 3D lithium-ion battery technology that delivers transformational performance at a competitive cost using non-toxic materials with the ability to customize shapes. Since its incorporation, Prieto has made significant strides in achieving its goal to produce a truly disruptive and transformational battery technology through its patented 3D battery architecture. Alongside the technology, Prieto has also patented a unique electroplating manufacturing process for its battery that uses non-toxic materials and will be price competitive. Prieto’s lab and headquarters are based in Fort Collins, Colo. For more information, please contact Katie M. Hoffner, Senior VP of Strategy, at [email protected], or visit www.prietobattery.com.
About Moses Lake Industries
MLI was established in 1984 as a wholly owned subsidiary of Tama Chemicals with global headquarters in Moses Lake, WA. They have manufacturing facilities in the U.S. and China, and partners and subsidiaries in Japan, Korea, Taiwan, and Singapore to ensure reliable and efficient delivery of their chemistries and world-class service to customers around the globe. They have consistently been the recipient of the Intel Supplier Continuous Quality Improvement Award. For more information on MLI, please contact Mark Willey, Senior Director of Technology, at [email protected], or visit http://www.mlindustries.com.
MEDIA CONTACT Katie M. Hoffner Senior Vice President Strategy [email protected]


Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings
Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand
Australia Targets Meta, Google, and TikTok With New News Payment Tax Proposal
Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition
Ford Q1 Earnings Beat Expectations, Stock Surges on Strong Guidance
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 



